Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | 1Globe Biomedical present in-depth research report on Molecular Colorectal Cancer1Globe Biomedical today presented their comprehensive global study on Molecular Colorectal Cancer with research spanning 5 years from 2015 to 2020.
1Globe Biomedical's research team carried out an in-depth analysis to understand all of the factors shaping its growth trajectory using advanced cell testing and this particular research is likely to play a vital role in the years to come. 1Globe Biomedical's Chief Medical Officer commented on the Molecular Colorectal Cancer saying "The outbreak of the COVID-19 pandemic which has now caused massive problems of unexpected proportions has shifted the global focus towards the healthcare market. The world's governments are closely working with healthcare institutions and pharmaceutical companies to provide effective treatments for the virus." 1Globe Biomedical's Chief Medical Officer also added "As a result of the ongoing COVID-19 pandemic, the focus has been shifted to medical priorities across healthcare institutions with treatment for COVID-19 infected patients being the most urgent to treat, and we think that this is sure to impact the growth of Molecular Colorectal Cancer cells." About Us - 1Globe Biomedical 1Globe Biomedical is a clinical stage biotechnology company pioneering the development of receptor T (1BioCARs™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of "off-the-shelf" http://1globe- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|